Shareholding disclosure

Basilea Pharmaceutica Ltd

Declared position

33.25%

Threshold

Crossed downwards

Timeline

Published

30.06.2021

Transaction

24.06.2021

Voting rights breakdown

Voting rights acquired8.81%

Voting rights sold33.25%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL6P00020

Beneficial owner

Basilea Pharmaceutica Ltd

Declared address

Basilea Pharmaceutica Ltd., 4058 Basel

Cancellation of bonds

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Basilea Pharmaceutica Ltd

Basilea Pharmaceutica AG, Allschwil30.06.2021TAL6P00020

Disclosure summary

Basilea Pharmaceutica Ltd disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the disposal side, published by SIX Exchange Regulation on 30.06.2021, at 33.25% of voting rights. Notice category: Single shareholder.

Disclosed position

33.25%

Voting rights sold

Voting rights acquired8.81%

Voting rights sold33.25%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Basilea Pharmaceutica Ltd disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 30.06.2021.

Publication date30.06.2021

Transaction date24.06.2021

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerBasilea Pharmaceutica Ltd

Declared addressBasilea Pharmaceutica Ltd., 4058 Basel

CategorySingle shareholder

Voting rights acquired8.81%

Voting rights sold33.25%

Below threshold0%

ExchangeXSWX

Notification IDTAL6P00020

Conditions

Cancellation of bonds

Source: SIX Exchange Regulation · Publication date: 30.06.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open